OBSERVATIONAL STUDY ON THE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN AN ULCERATIVE COLITIS POPULATION COMPRISED BY BIO-NAÏVE PATIENTS AND PATIENTS WITH FAILURE OF ONE PREVIOUS ANTI-TNF (EVOLVE-IB STUDY)

Francisco Casellas  ¹     Cristina Rodriguez  ²     Javier Pérez Gisbert  ³     Ana Gutiérrez-Casbas  ⁴     Isabel Vera Mendoza  ⁵     Sabino Riestra  ⁶     Pilar Martínez-Montiel  ⁷     María Dolores Martín-Arranz  ⁸     Vanesa Royo  ⁹     Patricia Suárez  ¹⁰     Orlando Garcia-Bosch  ¹¹     Esther García-Planella  ¹²     Marisa Iborra  ¹³     Jesus Aparicio  ¹⁴     Alonso Fernandez-Nistal  ¹⁴     Ignacio Tagarro  ¹⁴     Carmen Montoto  ¹⁴     Fernando Muñoz  ^15    
1 Hospital Universitari Vall d'Hebron, Barcelona, Spain
² Complejo Hospitalario de Navarra, Pamplona, Spain
³ Hospital Universitario de La Princesa, Madrid, Spain
⁴ Hospital General Universitario de Alicante, Alicante, Spain
⁵ Hospital Puerta de Hierro Majadahonda, Madrid, Spain
⁶ Hospital Universitario Central de Asturias, Oviedo, Spain
⁷ Hospital Universitario 12 de Octubre, Madrid, Spain
⁸ La Paz University Hospital, Madrid, Spain
⁹ Hospital Universitario Son Espases, Palma, Spain
¹⁰ Complejo Asistencial Universitario de León, León, Spain
¹¹ Hospital de Sant Joan Despí Moisès Broggi, Barcelona, Spain
¹² Hospital de Sant Pau, Barcelona, Spain
¹³ La Fe University and Polytechnic Hospital, Valencia, Spain
¹⁴ Takeda Farmacéutica España S.A., Madrid, Spain
¹⁵ Complejo Asistencial Universitario de Salamanca, Salamanca, Spain

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)